Coronavirus: Immune Thrombocytopenic Purpura

(asked on 10th January 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 December 21 to Question 86034 on Coronavirus: Immune Thrombocytopenic Purpura, what steps his department is taking to investigate the 427 suspected cases of major thromboembolic events with concurrent thrombocytopenia; and if the Government will make it its policy to those affected by those suspected cases of the availability of the Vaccine Damage Payment Scheme.


Answered by
Maria Caulfield Portrait
Maria Caulfield
Parliamentary Under-Secretary (Department of Health and Social Care)
This question was answered on 13th January 2022

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

This content was generated for your convenience by Parallel Parliament and does not form part of the official record.
Recent Documents related to Coronavirus: Immune Thrombocytopenic Purpura

1. Coronavirus vaccine - weekly summary of Yellow Card reporting
09/12/2021 - Medicines and Healthcare products Regulatory Agency
- View source

Found: monitoring role includes reviewing reports of suspected side effects . A ny member of the public or health

2. Swine flu vaccines and antiviral medicines UK post-pandemic safety review
18/06/2021 - Medicines and Healthcare products Regulatory Agency
- View source

Found: started across the UK to help prevent future cases of swine flu. The injected vaccines were offered

3. PRAC recommendations on signals adopted at April 2019 meeting.
19/06/2019 - Medicines and Healthcare products Regulatory Agency
- View source

Found: www.ema.europa.eu/how -to -find -us Send us a question Go to www.ema.europa.eu/contact Telephone

4. Drug Safety Update: monthly PDF newsletter
21/11/2019 - Medicines and Healthcare products Regulatory Agency
- View source

Found: formulations): reports of serious and fatal thromboembolic events page 6 Medicines with teratogenic

5. Cervarix (HPV) vaccine update on UK safety in the first 2 years of the HPV immunisation programme
18/06/2021 - Medicines and Healthcare products Regulatory Agency
- View source

Found: cervical c cancer, and is responsible for nearly 3000 cases of this cancer every year in the UK. By immunising

Latest Documents
Recent Speeches related to Coronavirus: Immune Thrombocytopenic Purpura

1. Public Health
30/11/2021 - Commons Chamber

1: taking steps to respond to a potentially potent mutation of the virus. We have taken great steps in our - Speech Link
2: variant of concern known as omicron emerged. Public health officials in South Africa shared information on - Speech Link
3: advice. I listened carefully to the Minister’s answer and I do not think that is quite what she said - Speech Link

2. Covid-19 Update
06/12/2021 - Commons Chamber

1: to the latest data, there are now 261 confirmed cases in England, 71 in Scotland and four in Wales, bringing - Speech Link

3. Covid-19: Immunology Research
09/09/2021 - Westminster Hall

1: the Prime Minister put the Minister for Covid Vaccine Deployment, who is present, in charge of making - Speech Link

4. Covid-19
11/11/2020 - Commons Chamber

1: support the economy, education and our NHS until a vaccine can be deployed, and in doing so, to ensure that - Speech Link
2: surgeries and care and treatment in our hospitals means that unless we keep the coronavirus rate under control - Speech Link
3: people who need hospitalisations to maintain the availability of those hospital beds for other people in dire - Speech Link

5. Covid-19
22/10/2020 - Commons Chamber

1: covid-19.The House meets today to debate the coronavirus pandemic once more. The peril of the pandemic - Speech Link
2: course this is a dangerous disease and, of course, cases are rising, including in my own area, so it is with - Speech Link
3: number of deaths will increase if the number of cases increase exponentially, hence the need for the actions - Speech Link

Latest Speeches
Recent Questions related to Coronavirus: Immune Thrombocytopenic Purpura
1. Coronavirus: Vaccine Damage Payment Scheme
asked by: Christopher Chope
21/12/2021
... (b) been rejected and (c) are still under consideration as of 2 December 2021 as of 2 December 2021.

2. Vaccine Damage Payment Scheme: Coronavirus
asked by: Christopher Chope
25/10/2021
... how many applications her Department has received under the Vaccine Damage Payments Act 1979 in respect of covid-19 vaccines; how many applications have been (a) rejected and (b) accepted; and how many staff are engaged in processing those applications.

3. Vaccine Damage Payment Scheme: Coronavirus
asked by: Christopher Chope
11/01/2021
... if he will make it his policy make the Vaccine Damage Payment Scheme open to anyone who suffers serious injury following vaccination against covid-19 ;and if he will make a statement.

4. Coronavirus: Vaccine Damage Payment Scheme
asked by: Hannah Bardell
05/01/2022
... whether any payments have been made under the Vaccine Damage Payment Scheme relating to covid-19 vaccinations.

5. Coronavirus: Vaccine Damage Payment Scheme
asked by: Hannah Bardell
05/01/2022
... whether the Vaccine Damage Payment Scheme will make payments to applicants diagnosed with Guillain-Barre syndrome in the context of that syndrome having been added to the list of side effects for the AstraZeneca covid-19 vaccination.

Latest Questions